Pith. sign in

REVIEW 3 major objections 4 minor 85 references

In vivo 4D x-ray dark-field lung imaging in mice

T0 review · 3 major / 4 minor · reviewed 2026-08-12 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read This paper claims the first in vivo 4D x-ray dark-field lung imaging in mice, achieved by synchronizing single-exposure grid-based imaging with the breath cycle, and shows that the time-resolved dark-field signal tracks regional alveolar…

desk verdict First real 4D dark-field lung CT; the breath-repeatability assumption needs an explicit check before the temporal curves are taken at face value. read the letter →

arxiv 2411.14669 v1 pith:MSMCYLTU submitted 2024-11-22 physics.med-ph

Ying Ying How , Nicole Reyne , Michelle K. Croughan , Patricia Cmielewski , Daniel Batey , Lucy F. Costello , Ronan Smith , Jannis N. Ahlers
show 9 more authors
Marian Cholewa Magdalena Kolodziej Julia Duerr Marcus A. Mall Marcus J. Kitchen Marie-Liesse Asselin-Labat David M. Paganin Martin Donnelley Kaye S. Morgan
This is my paper · ORCID
classification physics.med-ph
keywords x-raydark-fieldimagingsingle-gridtime-resolvedcomputedtomographylunginvivomousemodelsalveolarfunctionrespiratorygatingphase-contrast
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper reports the first time-resolved three-dimensional (4D) x-ray dark-field imaging of living mouse lungs. It combines single-exposure grid-based dark-field retrieval with ventilation-synchronized acquisition: projections taken at eight equally spaced points in the breath cycle, across 1800 breaths, are binned into eight CT volumes. The authors show that the dark-field signal, which arises from unresolved alveoli, drops as the lungs inflate and recovers as they deflate, and that diseased lungs (muco-obstructive disease/emphysema and lung cancer) show weaker signals and flatter temporal responses than a control. If the method holds up, it turns dark-field CT into a functional imaging tool that can map regional alveolar expansion, information absent from attenuation CT, and could assess lung disease locally rather than through whole-lung averages.

What carries the argument

The load-bearing mechanism is single-grid dark-field retrieval: a periodic attenuating grid placed upstream of the sample casts a shadow pattern on the detector, and comparing the sample-and-grid image with a grid-only image yields the visibility ratio $V=\exp(-\mu_d T)$, where $\mu_d$ is the linear diffusion coefficient and $T$ is the thickness. Because the dark-field signal is extracted from a single exposure, 62 ms per projection, no grating stepping is needed. The second mechanism is ventilation-gated acquisition: a timing hub triggered by the ventilator records images at eight equally spaced breath points while the mouse rotates continuously, so 1800 breaths produce eight self-consistent 180-degree projection sets that are reconstructed by filtered back-projection into eight dark-field CT volumes. The $\mu_d$ value is interpreted as proportional to the surface-area-to-volume ratio of the unresolved alveoli, which is what makes the temporal dark-field curve a proxy for alveolar expansion.

What would settle it

Repeatedly scan the same mouse under identical ventilation and compare the eight reconstructed timepoints between scans, or deliberately change ventilation (for example, different PEEP or a single induced atelectasis in one lobe) and check whether the dark-field time course for the affected region flattens or misregisters. A direct quantitative test: at a fixed trigger point, measure the displacement of the diaphragm or a bronchial bifurcation across many breaths; if the lung position varies by more than one reconstructed voxel, the gating assumption underpinning the eight CT volumes is violated.

Watch

Extended reading notes

Core claim

The central claim is that 4D dark-field CT of breathing mouse lungs is feasible with a single-exposure grid-based setup, and that the reconstructed dark-field signal tracks alveolar size changes throughout the breath cycle. In the data, the median dark-field signal in a mid-lung slice falls to a minimum at the inhalation timepoint and returns during exhalation, consistent with alveoli expanding then contracting; the attenuation images over the same breath points look nearly identical. Spatial comparisons show dark-field contrast between lung lobes that is far weaker in attenuation CT (contrast-to-noise ratio 5.5 versus 2.4), and post-mortem high-resolution CT confirms that the lobe with weaker dark-field signal contains larger alveoli. In the β-ENaC-Tg and lung-cancer mice, dark-field signals are lower and change less through the breath than in the control, consistent with enlarged alveoli, tumour-obstructed airflow, or a reduced alveolar fraction. The paper presents these as proof-of-principle demonstrations rather than cohort statistics.

Load-bearing premise

The approach assumes that at the same trigger point in every breath the lungs are in the same position and inflation state, so 1800 separate breaths can be pooled into eight consistent CT datasets; if breathing drifts or the lung does not return to the same state, the time-resolved dark-field curves blur.

Editorial extensions

If this is right

  • Regional lung function can be read out voxel by voxel: dark-field CT maps where alveoli are larger or more loosely packed, and how much they expand during a breath, rather than averaging the whole lung into a single number.
  • Disease models show a measurable signature: compared with control lung, muco-obstructive/emphysema and lung-cancer lungs exhibit weaker dark-field signal and smaller breath-to-breath variation, suggesting the technique can characterize alveolar destruction or airflow obstruction.
  • Because $\mu_d$ is proportional to surface-area-to-volume ratio, the eight timepoints give a local alveolar expansion curve, so the technique could quantify regional lung mechanics without contrast agents.
  • The same synchronized single-exposure protocol can in principle be applied to other periodic sample changes, such as metal-foam formation or dissolving microstructures, by collecting multiple rotations instead of one.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • If breath-to-breath reproducibility holds in larger cohorts, the same eight-point gating could be extended to cardiac gating with a high-brightness source, removing the remaining motion artefact the authors note.
  • The parameter-free link between $\mu_d$ and surface-area-to-volume ratio suggests a direct quantitative endpoint for preclinical drug trials: a treatment that restores alveolar expansion should raise the dark-field temporal swing back toward control values.
  • Moving to laboratory x-ray sources would require correcting beam-hardening and visibility-hardening biases that alter quantitative $\mu_d$; without those corrections, lab-based 4D dark-field CT would likely be only qualitative.
  • The manual slice alignment used for ROI tracking could be automated with image registration or x-ray velocimetry, which would make regional dark-field measurements less operator-dependent and better suited to blinded studies.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 4 minor

Summary. The paper presents a proof-of-principle demonstration of time-resolved three-dimensional x-ray dark-field imaging of living mouse lungs. Using a single-grid setup at 25 keV, the authors synchronized image acquisition with a mechanical ventilator, binning projections from 1800 breaths into eight equally spaced breath-phase points, and reconstructed dark-field CT volumes via filtered backprojection of the retrieved visibility signal. Data are shown for one control mouse, one β-ENaC-Tg mouse (muco-obstructive disease/emphysema), and one KP lung-cancer mouse. The authors report that dark-field CT provides contrast between lung lobes not visible in attenuation CT, that dark-field signal decreases during inhalation and recovers during exhalation in the control, and that the disease models show weaker and flatter temporal dark-field responses. The central claim is that this is the first in vivo 4D x-ray dark-field lung imaging.

Significance. If the central claim holds, this is a significant technical advance: it combines single-exposure dark-field retrieval with gated acquisition to obtain 4D dark-field CT, something not previously demonstrated. The work is explicitly a proof-of-principle with one animal per model, and the authors are candid about the need for future cohort studies. The quantitative link to the linear diffusion coefficient µd and its proportionality to alveolar surface-area-to-volume ratio (from prior work) gives a plausible path to functional lung assessment. The main strengths are the clean experimental design, the use of a well-characterized retrieval algorithm, and the clear presentation of the temporal dark-field trends.

major comments (3)
  1. [Section II-D] The temporal reconstruction assumes the lungs return to the same position and inflation state at the same time point in every breath cycle, yet no validation of this assumption is provided. The eight phase-binned CT datasets are each assembled from projections acquired over 1800 separate breaths, and the 62 ms projection time covers roughly 11% of the 500 ms breath cycle. Ventilator trigger jitter, tidal-volume fluctuations, or slow drift (e.g., atelectasis, mucus accumulation) would mix different lung states into a single bin and could artifactually flatten or shift the dark-field temporal curves in Figs. 4 and 5. Please add a quantitative check, for example: report the measured trigger jitter, compare repeated projections acquired at the same rotation angle and breath point, or plot the attenuation-derived lung volume per bin as a consistency diagnostic. Without such a check, the physiological interpretation of the temporal dark-field decrease at T2 is not fully supported.
  2. [Section IV, Figs. 4 and 5] The cross-model comparisons are based on one animal per group (n=1) and the plotted medians have no error bars or uncertainty estimates. The claim that the β-ENaC-Tg and cancer lungs generate weaker dark-field signals and smaller relative changes in magnitude compared to the control lung is therefore not statistically grounded. At minimum, please provide the spread of the dark-field values across the slices or voxels used in each ROI, or a noise estimate propagated from the retrieval algorithm, and state explicitly that the cross-model differences are illustrative single-animal observations.
  3. [Section III-C] The manual slice alignment and manual ROI masks are a source of potential bias in the measured temporal dark-field curves. The alignment is performed on the attenuation CT and then applied to the dark-field CT, but the two modalities have different effective spatial resolution (the dark-field analysis decimates by a factor of 10 in projection space) and may not co-register perfectly. Please quantify the sensitivity of the Fig. 4 and Fig. 5 curves to alignment choices (e.g., ±1 slice) and to mask boundaries, or replace the manual steps with automated registration.
minor comments (4)
  1. [Section III-B, Eq. (1)] Please state explicitly that the CT reconstruction is applied to -ln(V) projection data (as is done for attenuation) in order to map µd; otherwise the reader may assume the visibility itself is being reconstructed.
  2. [Fig. 4 caption] The text and caption refer to the 'whole lung' measurement, but this is a median over a single 97-µm axial slice, not over the entire lung volume.
  3. [Abstract and Introduction] The phrase 'the first in vivo 4D x-ray dark-field lung imaging' appears as a categorical statement; adding 'to our knowledge' would be more precise given the rapid evolution of the field.
  4. [Section V-A] The statement that a 20% increase in µd implies a 20% increase in surface-area-to-volume ratio should reference the validity conditions of the proportionality derived in [67]; as written it could be read as a universal relation.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity; the 4D dark-field result is a direct measurement using externally validated algorithms and prior physical relations.

full rationale

The paper's load-bearing chain is: (i) acquire single-exposure grid images synchronised to ventilation; (ii) retrieve dark-field visibility from each projection using the published single-grid algorithm [26]; (iii) reconstruct µd CT via Eq. (1); (iv) bin projections by breath phase and compare µd across phases. None of these steps fits a parameter to the result it then 'predicts.' The retrieval algorithm [26] and the µd-to-surface-area-to-volume relation [67] are self-cited, but they are used as external, previously validated tools: [26] is an algorithm whose output V is directly measured from the visibility ratio, and [67] is a theoretical proportionality not fitted to the mice in this paper. The temporal dark-field curves are direct measurements, not the output of a model fitted to those same curves. The Section II-D breath-repeatability assumption is a correctness precondition for 4D reconstruction, not a circular definition; if breaths drift, the result would be inaccurate rather than true by construction. No equation here reduces a conclusion to an input, and no fitted parameter is renamed as a prediction. The only self-citations appear in method descriptions and future-work suggestions, so the score is 0.

Assumptions & free parameters 4 free parameters · 4 assumptions · 0 invented entities

The central claim rests on the periodicity of the breath cycle, the validity of the previously published single-grid retrieval algorithm, the rotational symmetry of alveolar scattering, and the standard interpretation of µd as a surface-area-to-volume measure. These are reasonable domain assumptions for a proof-of-principle, but none are re-validated in this dataset. Experimental setup choices (propagation distance, number of breath points, processing parameters) are hand-selected rather than derived.

free parameters (4)
  • Sample-to-detector propagation distance = 3.5 m
    Chosen experimentally by visual inspection to balance grid visibility and dark-field blur detectability (Sections II-A and V-B). Not derived from a model; affects sensitivity and spatial resolution.
  • Number of breath points per cycle = 8
    Equally spaced timepoints across the ventilation cycle; a sampling choice that sets temporal resolution of the 4D reconstruction (Section II-D).
  • Cross-correlation window size = 16 pixels
    Set to match the grid period in the retrieval algorithm; a processing choice from prior work [26] (Section III-A).
  • Projection decimation step = every 10th pixel
    Chosen to minimize computing time; reduces spatial resolution of extracted signals (Section III-A).
assumptions (4)
  • domain assumption The lungs return to the same position and configuration at the same timepoint in every breath cycle, allowing projections from different breaths to be binned retrospectively.
    Stated in Section II-D; if the breath is not periodic, the CT reconstruction at each timepoint will be inconsistent.
  • domain assumption The single-grid dark-field retrieval algorithm of How and Morgan [26] yields an accurate visibility-based dark-field signal from a single exposure.
    The entire analysis depends on this algorithm; the paper applies it without re-deriving or validating it in this context (Section III-A).
  • domain assumption The x-ray scattering from the alveoli is rotationally symmetric, so that the anisotropic source-size blurring (visibility 0.08 horizontal vs 0.2 vertical) does not bias the scalar dark-field measurement.
    Acknowledged in Section V-C; the source-size blurring is significant in the horizontal direction but assumed not to affect the rotationally-symmetric alveolar signal.
  • domain assumption The dark-field linear diffusion coefficient µd is proportional to the surface-area-to-volume ratio of the alveoli, per Paganin, Pelliccia and Morgan [67].
    This is the physical basis for interpreting dark-field changes as alveolar size changes, cited in Sections V-A and VI; not independently verified in this dataset.

how reviews work

0 comments
Cite this review

Pith. "Pith review of In vivo 4D x-ray dark-field lung imaging in mice." pith.science (2026). https://pith.science/paper/MSMCYLTU

@misc{pith2026241114669,
  author       = {Pith},
  title        = {Pith review of: In vivo 4D x-ray dark-field lung imaging in mice},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/MSMCYLTU}},
  note         = {Machine review of arXiv:2411.14669}
}
read the original abstract

X-ray dark-field imaging is well-suited to visualizing the health of the lungs because the alveoli create a strong dark-field signal. However, time-resolved and tomographic (i.e., 4D) dark-field imaging is challenging, since most x-ray dark-field techniques require multiple sample exposures, captured while scanning the position of crystals or gratings. Here, we present the first in vivo 4D x-ray dark-field lung imaging in mice. This was achieved by synchronizing the data acquisition process of a single-exposure grid-based imaging approach with the breath cycle. The short data acquisition time per dark-field projection made this approach feasible for 4D x-ray dark-field imaging by minimizing the motion-blurring effect, the total time required and the radiation dose imposed on the sample. Images were captured from a control mouse and from mouse models of muco-obstructive disease and lung cancer, where a change in the size of the alveoli was expected. This work demonstrates that the 4D dark-field signal provides complementary information that is inaccessible from conventional attenuation-based CT images, in particular, how the size of the alveoli from different parts of the lungs changes throughout a breath cycle, with examples shown across the different models. By quantifying the dark-field signal and relating it to other physical properties of the alveoli, this technique could be used to perform functional lung imaging that allows the assessment of both global and regional lung conditions where the size or expansion of the alveoli is affected.

Figures

Figures reproduced from arXiv: 2411.14669 by the authors.

Figure 1
Figure 1. The experimental single-grid imaging setup for [PITH_FULL_IMAGE:figures/full_fig_p003_1.png] view at source ↗
Figure 2
Figure 2. A schematic diagram showing the synchronized image acquisition procedure. (a) Images were taken at 8 equally-spaced points (labelled with different [PITH_FULL_IMAGE:figures/full_fig_p004_2.png] view at source ↗
Figure 3
Figure 3. Representative example of the reconstructed (a) & (c) dark-field, [PITH_FULL_IMAGE:figures/full_fig_p005_3.png] view at source ↗
Figures from the paper (2 more)
Figure 4
Figure 4. Figure 4: The change in the dark-field signal from the lungs of a control mouse [PITH_FULL_IMAGE:figures/full_fig_p006_4.png]
Figure 5
Figure 5. Figure 5: Dark-field signals from different parts of the lungs at different breath [PITH_FULL_IMAGE:figures/full_fig_p006_5.png]

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

85 extracted references · 59 canonical work pages

  1. [1]

    D. M. Paganin, Coherent X-Ray Optics. Oxford University Press, 2006

    2006

  2. [2]

    Generalized diffraction enhanced imaging to retrieve absorption, refraction and scattering effects,

    L. Rigon, F. Arfelli, and R.-H. Menk, “Generalized diffraction enhanced imaging to retrieve absorption, refraction and scattering effects,” J. Phys. D Appl. Phys. , vol. 40, no. 10, pp. 3077–3089, May 2007, 10.1088/ 0022-3727/40/10/011

    2007

  3. [3]

    Hard-X-ray dark-field imaging using a grating interferometer,

    F. Pfeiffer et al. , “Hard-X-ray dark-field imaging using a grating interferometer,” Nat. Mater. , vol. 7, no. 2, pp. 134–137, Feb. 2008, 10.1038/nmat2096

    doi:10.1038/nmat2096 2008

  4. [4]

    Hard X-ray dark-field imaging with incoherent sample illumination,

    M. Endrizzi et al. , “Hard X-ray dark-field imaging with incoherent sample illumination,” Appl. Phys. Lett. , vol. 104, no. 2, Jan. 2014, Art. no. 024106, 10.1063/1.4861855

    work page doi:10.1063/1.4861855 2014

  5. [5]

    X-ray phase-contrast radiography and tomography with a mul- tiaperture analyzer,

    ——, “X-ray phase-contrast radiography and tomography with a mul- tiaperture analyzer,” Phys. Rev. Lett. , vol. 118, no. 24, Jun. 2017, Art. no. 243902, 10.1103/PhysRevLett.118.243902

    work page doi:10.1103/physrevlett.118.243902 2017

  6. [6]

    X-ray multimodal imaging using a random-phase object,

    S. Berujon, H. Wang, and K. Sawhney, “X-ray multimodal imaging using a random-phase object,” Phys. Rev. A. , vol. 86, no. 6, Dec

  7. [7]

    Speckle-based x-ray phase-contrast and dark-field imaging with a laboratory source,

    I. Zanette et al. , “Speckle-based x-ray phase-contrast and dark-field imaging with a laboratory source,” Phys. Rev. Lett. , vol. 112, no. 25, Jun. 2014, Art. no. 253903, 10.1103/PhysRevLett.112.253903

    work page doi:10.1103/physrevlett.112.253903 2014

  8. [8]

    X-ray phase-contrast imaging and metrology through unified modulated pattern analysis,

    M.-C. Zdora et al. , “X-ray phase-contrast imaging and metrology through unified modulated pattern analysis,” Phys. Rev. Lett. , vol. 118, no. 20, May 2017, Art. no. 203903, 10.1103/PhysRevLett.118.203903

    doi:10.1103/physrevlett.118.203903 2017

Show all 85 references
  1. [9]

    X-ray multi-modal intrinsic-speckle-tracking,

    K. M. Pavlov, D. M. Paganin, H. T. Li, S. Berujon, H. Roug ´e-Labriet, and E. Brun, “X-ray multi-modal intrinsic-speckle-tracking,” J. Opt. , vol. 22, no. 12, Nov. 2020, Art. no. 125604, 10.1088/2040-8986/abc313

    2020 doi

  2. [10]

    Dark-field tomography of an attenuating object using intrinsic x-ray speckle tracking,

    S. J. Alloo et al., “Dark-field tomography of an attenuating object using intrinsic x-ray speckle tracking,” J. Med. Imaging , vol. 9, no. 3, May 2022, Art. no. 031502, 10.1117/1.jmi.9.3.031502

    2022 doi

  3. [11]

    Fast implicit diffusive dark-field retrieval for single-exposure, single- mask x-ray imaging,

    M. A. Beltran, D. M. Paganin, M. K. Croughan, and K. S. Morgan, “Fast implicit diffusive dark-field retrieval for single-exposure, single- mask x-ray imaging,” Optica, vol. 10, no. 4, pp. 422–429, Apr. 2023, 10.1364/OPTICA.480489

    2023 doi

  4. [12]

    Dark-field signal extraction in propagation-based phase-contrast imaging,

    T. E. Gureyev et al., “Dark-field signal extraction in propagation-based phase-contrast imaging,” Phys. Med. Biol. , vol. 65, no. 21, Nov. 2020, Art. no. 215029, 10.1088/1361-6560/abac9d

    2020 doi

  5. [13]

    X-ray dark-field and phase retrieval without optics, via the Fokker–Planck equation,

    T. A. Leatham, D. M. Paganin, and K. S. Morgan, “X-ray dark-field and phase retrieval without optics, via the Fokker–Planck equation,” IEEE Trans. Med. Imaging , vol. 42, no. 6, pp. 1681–1695, Jan. 2023, 10.1109/TMI.2023.3234901

    2023

  6. [14]

    X-ray phase and dark-field computed tomography without optical elements,

    ——, “X-ray phase and dark-field computed tomography without optical elements,” Opt. Express, vol. 32, no. 3, pp. 4588–4602, Jan. 2024, 10. 1364/OE.509604

    2024

  7. [15]

    X- ray dark-field via spectral propagation-based imaging,

    J. N. Ahlers, K. M. Pavlov, M. J. Kitchen, and K. S. Morgan, “X- ray dark-field via spectral propagation-based imaging,” Optica, vol. 11, no. 8, pp. 1182–1191, Aug. 2024, 10.1364/OPTICA.506742

    2024 doi

  8. [16]

    Single- shot x-ray differential phase-contrast and diffraction imaging using two- dimensional transmission gratings,

    H. H. Wen, E. E. Bennett, R. Kopace, A. F. Stein, and V . Pai, “Single- shot x-ray differential phase-contrast and diffraction imaging using two- dimensional transmission gratings,” Opt. Lett., vol. 35, no. 12, pp. 1932– 1934, Jun. 2010, 10.1364/OL.35.001932

    1932 doi

  9. [17]

    A sensitive x-ray phase contrast technique for rapid imaging using a single phase grid analyzer,

    K. S. Morgan et al., “A sensitive x-ray phase contrast technique for rapid imaging using a single phase grid analyzer,” Opt. Lett., vol. 38, no. 22, pp. 4605–4608, Nov. 2013, 10.1364/OL.38.004605

    2013 doi

  10. [18]

    Direc- tional dark-field retrieval with single-grid x-ray imaging,

    M. K. Croughan, Y . Y . How, A. Pennings, and K. S. Morgan, “Direc- tional dark-field retrieval with single-grid x-ray imaging,” Opt. Express, vol. 31, no. 7, pp. 11 578–11 597, Mar. 2023, 10.1364/OE.480031

    2023 doi

  11. [19]

    Emphysema quantified: mapping regional airway dimensions using 2D phase contrast X-ray imaging,

    M. J. Kitchen et al., “Emphysema quantified: mapping regional airway dimensions using 2D phase contrast X-ray imaging,” Biomed. Opt. Ex- press, vol. 11, no. 8, pp. 4176–4190, Aug. 2020, 10.1364/BOE.390587

    2020 doi

  12. [20]

    Quantitative x-ray dark-field computed tomography,

    M. Bech, O. Bunk, T. Donath, R. Feidenhans, C. David, and F. Pfeiffer, “Quantitative x-ray dark-field computed tomography,” Phys. Med. Biol., vol. 55, no. 18, pp. 5529–5539, Aug. 2010, 10.1088/0031-9155/55/18/ 017

    2010 doi

  13. [21]

    Interpretation of dark-field contrast and particle-size selectivity in grating interferometers,

    S. K. Lynch et al., “Interpretation of dark-field contrast and particle-size selectivity in grating interferometers,” Appl. Opt. , vol. 50, no. 22, pp. 4310–4319, Jul. 2011, 10.1364/AO.50.004310

    2011 doi

  14. [22]

    A generalized quantitative interpretation of dark-field contrast for highly concentrated microsphere suspensions,

    S. Gkoumas, P. Villanueva-Perez, Z. Wang, L. Romano, M. Abis, and M. Stampanoni, “A generalized quantitative interpretation of dark-field contrast for highly concentrated microsphere suspensions,” Sci. Rep. , vol. 6, Oct. 2016, Art. no. 35259, 10.1038/srep35259

    2016 doi

  15. [23]

    Short-range order in mesoscale systems probed by X-ray grating interferometry,

    F. Prade, A. Yaroshenko, J. Herzen, and F. Pfeiffer, “Short-range order in mesoscale systems probed by X-ray grating interferometry,” Europhys. Lett., vol. 112, no. 6, Jan. 2016, Art. no. 68002, 10.1209/0295-5075/ 112/68002

    2016 doi

  16. [24]

    Sub-pixel correlation length neutron imaging: Spatially resolved scattering information of microstructures on a macroscopic scale,

    R. P. Harti, M. Strobl, B. Betz, K. Jefimovs, M. Kagias, and C. Gr ¨unzweig, “Sub-pixel correlation length neutron imaging: Spatially resolved scattering information of microstructures on a macroscopic scale,” Sci. Rep. , vol. 7, no. 1, Mar. 2017, Art. no. 44588, 10.1038/ srep44588

    2017

  17. [25]

    Interpretation and utility of the moments of small- angle x-ray scattering distributions,

    P. Modregger et al., “Interpretation and utility of the moments of small- angle x-ray scattering distributions,” Phys. Rev. Lett. , vol. 118, no. 26, Jun. 2017, Art. no. 265501, 10.1103/physrevlett.118.265501

    2017 doi

  18. [26]

    Quantifying the x-ray dark-field signal in single-grid imaging,

    Y . Y . How and K. S. Morgan, “Quantifying the x-ray dark-field signal in single-grid imaging,” Opt. Express, vol. 30, no. 7, pp. 10 899–10 918, Mar. 2022, 10.1364/OE.451834

    2022 doi

  19. [27]

    On the quantification of sample microstructure using single-exposure x-ray dark-field imaging via a single-grid setup,

    Y . Y . How, D. M. Paganin, and K. S. Morgan, “On the quantification of sample microstructure using single-exposure x-ray dark-field imaging via a single-grid setup,” Sci. Rep. , vol. 13, no. 1, Jul. 2023, Art. no. 11001, 10.1038/s41598-023-37334-3

    2023 doi

  20. [28]

    On the origin of visibility contrast in x-ray Talbot interferometry,

    W. Yashiro, Y . Terui, K. Kawabata, and A. Momose, “On the origin of visibility contrast in x-ray Talbot interferometry,” Opt. Express, vol. 18, no. 16, pp. 16 890–16 901, Aug. 2010, 10.1364/OE.18.016890

    2010 doi

  21. [29]

    Phase contrast x-ray imaging signatures for security applications,

    E. A. Miller, T. A. White, B. S. McDonald, and A. Seifert, “Phase contrast x-ray imaging signatures for security applications,” IEEE Trans. Nucl. Sci. , vol. 60, no. 1, pp. 416–422, Jan. 2013, 10.1109/TNS.2012. 2227803

    2013 doi

  22. [30]

    Enhanced detection of threat materials by dark-field x-ray imaging combined with deep neural networks,

    T. Partridge et al., “Enhanced detection of threat materials by dark-field x-ray imaging combined with deep neural networks,” Nat. Commun. , vol. 13, no. 1, Sep. 2022, Art. no. 4651, 10.1038/s41467-022-32402-0

    2022 doi

  23. [31]

    Characterization of oriented microstructures through anisotropic small-angle scattering by 2D neutron dark-field imaging,

    J. Valsecchi et al., “Characterization of oriented microstructures through anisotropic small-angle scattering by 2D neutron dark-field imaging,” Commun. Phys. , vol. 3, no. 1, Feb. 2020, Art. no. 42, 10.1038/ s42005-020-0308-4

    2020

  24. [32]

    Non-invasive differentiation of kidney stone types using X-ray dark-field radiography,

    K. Scherer et al. , “Non-invasive differentiation of kidney stone types using X-ray dark-field radiography,” Sci. Rep., vol. 5, no. 1, Apr. 2015, Art. no. 9527, 10.1038/srep09527

    2015 doi

  25. [33]

    The classification of renal stones by gratings-based dark-field radiography,

    T. Niemann, I. Jerjen, L. Hefermehl, Z. Wang, R. A. Kubik-Huch, and M. Stampanoni, “The classification of renal stones by gratings-based dark-field radiography,” Cent. European J. Urol. , vol. 74, no. 3, Sep. 2021, Art. no. 453, 10.5173/ceju.2021.3.0334

    2021 doi

  26. [34]

    On a dark-field signal generated by micrometer- sized calcifications in phase-contrast mammography,

    T. Michel et al. , “On a dark-field signal generated by micrometer- sized calcifications in phase-contrast mammography,” Phys. Med. Biol. , vol. 58, no. 8, pp. 2713–2732, Apr. 2013, 10.1088/0031-9155/58/8/2713

    2013 doi

  27. [35]

    Non-invasive classification of microcalcifications with phase-contrast X-ray mammography,

    Z. Wang et al., “Non-invasive classification of microcalcifications with phase-contrast X-ray mammography,” Nat. Commun., vol. 5, no. 1, May 2014, Art. no. 3797, 10.1038/ncomms4797

    2014 doi

  28. [36]

    Can grating interferometry-based mammography dis- criminate benign from malignant microcalcifications in fresh biopsy samples?

    S. Forte et al. , “Can grating interferometry-based mammography dis- criminate benign from malignant microcalcifications in fresh biopsy samples?” Eur. J. Radiol. , vol. 129, Aug. 2020, Art. no. 109077, 10.1016/j.ejrad.2020.109077

    2020

  29. [37]

    Imaging breast microcalcifications using dark- field signal in propagation-based phase-contrast tomography,

    A. Aminzadeh et al. , “Imaging breast microcalcifications using dark- field signal in propagation-based phase-contrast tomography,” IEEE Trans. Med. Imaging , vol. 41, no. 11, pp. 2980–2990, May 2022, 10.1109/TMI.2022.3175924

    2022

  30. [38]

    Dark-field x-ray imaging for the assessment of osteoporosis in human lumbar spine specimens,

    F. T. Gassert et al. , “Dark-field x-ray imaging for the assessment of osteoporosis in human lumbar spine specimens,”Front. Psychol., vol. 14, Jul. 2023, Art. no. 1217007, 10.3389/fphys.2023.1217007

    2023

  31. [39]

    Feasibility of dark-field radiography to enhance detection of nondisplaced fractures,

    F. Schaff et al. , “Feasibility of dark-field radiography to enhance detection of nondisplaced fractures,” Radiology, vol. 311, no. 2, May 2024, Art. no. e231921, 10.1148/radiol.231921

    2024 doi

  32. [40]

    Emphysema diagnosis using x-ray dark-field imaging at a laser-driven compact synchrotron light source,

    S. Schleede, F. G. Meinel, M. Bech, J. Herzen, K. Achterhold, G. Pot- devin, A. Malecki, S. Adam-Neumair, S. F. Thieme, F. Bamberg et al., “Emphysema diagnosis using x-ray dark-field imaging at a laser-driven compact synchrotron light source,” Proc. Natl. Acad. Sci. , vol. 109...

    2012 doi

  33. [41]

    Pulmonary emphysema diagnosis with a preclin- ical small-animal x-ray dark-field scatter-contrast scanner,

    A. Yaroshenko et al., “Pulmonary emphysema diagnosis with a preclin- ical small-animal x-ray dark-field scatter-contrast scanner,” Radiology, vol. 269, no. 2, pp. 427–433, Nov. 2013, 10.1148/radiol.13122413

    2013 doi

  34. [42]

    X-ray dark-field radiography – in-vivo diagnosis of lung cancer in mice,

    K. Scherer et al. , “X-ray dark-field radiography – in-vivo diagnosis of lung cancer in mice,” Sci. Rep., vol. 7, no. 1, Mar. 2017, Art. no. 402, 10.1038/s41598-017-00489-x

    2017 doi

  35. [43]

    In vivo dark-field radiography for early diagnosis and staging of pulmonary emphysema,

    K. Hellbach et al. , “In vivo dark-field radiography for early diagnosis and staging of pulmonary emphysema,” Invest. Radiol., vol. 50, no. 7, pp. 430–435, Jul. 2015, 10.1097/rli.0000000000000147

    2015 doi

  36. [44]

    X-ray dark-field radiography facilitates the diagnosis of pul- monary fibrosis in a mouse model,

    ——, “X-ray dark-field radiography facilitates the diagnosis of pul- monary fibrosis in a mouse model,” Sci. Rep., vol. 7, no. 1, Mar. 2017, Art. no. 340, 10.1038/s41598-017-00475-3

    2017 doi

  37. [45]

    X-ray dark-field chest imaging: qualitative and quantitative results in healthy humans,

    F. T. Gassert et al. , “X-ray dark-field chest imaging: qualitative and quantitative results in healthy humans,” Radiology, vol. 301, pp. 389– 395, Nov. 2021, 10.1148/radiol.2021210963

    2021 doi

  38. [46]

    Dark-field chest x-ray imaging for the assessment of COVID-19-pneumonia,

    M. Frank et al., “Dark-field chest x-ray imaging for the assessment of COVID-19-pneumonia,” Commun. Med., vol. 2, no. 1, Nov. 2022, Art. no. 147, 10.1038/s43856-022-00215-3

    2022 doi

  39. [47]

    X-ray dark-field chest imaging for detection and quan- tification of emphysema in patients with chronic obstructive pulmonary disease: a diagnostic accuracy study,

    K. Willer et al., “X-ray dark-field chest imaging for detection and quan- tification of emphysema in patients with chronic obstructive pulmonary disease: a diagnostic accuracy study,”Lancet Digit Health, vol. 3, no. 11, pp. e733–e744, Nov. 2021, 10.1016/s2589-7500(21)00146-1

    2021 doi

  40. [48]

    Dark-field chest radiography outperforms conven- tional chest radiography for the diagnosis and staging of pulmonary emphysema,

    T. Urban et al. , “Dark-field chest radiography outperforms conven- tional chest radiography for the diagnosis and staging of pulmonary emphysema,” Invest. Radiol., vol. 58, no. 11, pp. 775–781, Nov. 2023, 10.1097/RLI.0000000000000989

    2023 doi

  41. [49]

    Dark-field computed tomography reaches the human scale,

    M. Viermetz et al., “Dark-field computed tomography reaches the human scale,” Proc. Natl. Acad. Sci. , vol. 119, no. 8, Feb. 2022, Art. no. e2118799119, 10.1073/pnas.2118799119

    2022 doi

  42. [50]

    Diagnosing and mapping pulmonary emphysema on X-ray projection images: incremental value of grating-based X-ray dark-field imaging,

    F. G. Meinel et al. , “Diagnosing and mapping pulmonary emphysema on X-ray projection images: incremental value of grating-based X-ray dark-field imaging,” PloS ONE, vol. 8, no. 3, Mar. 2013, Art. no. e59526, 10.1371/journal.pone.0059526

    2013 doi

  43. [51]

    In-vivo x-ray dark-field chest radiography of a pig,

    L. B. Gromann et al. , “In-vivo x-ray dark-field chest radiography of a pig,” Sci. Rep. , vol. 7, no. 1, Jul. 2017, Art. no. 4807, 10.1038/ s41598-017-05101-w

    2017

  44. [52]

    Dynamic in vivo chest x-ray dark-field imaging in mice,

    R. Gradl et al. , “Dynamic in vivo chest x-ray dark-field imaging in mice,” IEEE Trans. Med. Imaging , vol. 38, no. 2, pp. 649–656, Sep. 2018, 10.1109/tmi.2018.2868999

    2018

  45. [53]

    Quantitative single- exposure x-ray phase contrast imaging using a single attenuation grid,

    K. S. Morgan, D. M. Paganin, and K. K. Siu, “Quantitative single- exposure x-ray phase contrast imaging using a single attenuation grid,” Opt. Express, vol. 19, no. 20, pp. 19 781–19 789, Sep. 2011, 10.1364/ OE.19.019781

    2011

  46. [54]

    Increased airway epithelial na+ absorption produces cystic fibrosis-like lung disease in mice,

    M. Mall, B. R. Grubb, J. R. Harkema, W. K. O’Neal, and R. C. Boucher, “Increased airway epithelial na+ absorption produces cystic fibrosis-like lung disease in mice,” Nat. Med., vol. 10, no. 5, pp. 487–493, May 2004, 10.1038/nm1028

    2004 doi

  47. [55]

    Development of chronic bronchitis and emphysema in β-epithelial Na + channel–overexpressing mice,

    M. A. Mall et al., “Development of chronic bronchitis and emphysema in β-epithelial Na + channel–overexpressing mice,” Am. J. Respir. Crit. Care Med. , vol. 177, no. 7, pp. 730–742, Apr. 2008, 10.1164/rccm. 200708-1233OC

    2008 doi

  48. [56]

    Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases,

    Z. Zhou-Suckow, J. Duerr, M. Hagner, R. Agrawal, and M. A. Mall, “Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases,” Cell Tissue Res. , vol. 367, pp. 537–550, Mar. 2017, 10.1007/s00441-016-2562-z

    2017 doi

  49. [57]

    In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography,

    M. O. Wielp ¨utz et al. , “In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography,” Eur. Respir. J., vol. 38, no. 5, pp. 1060–1070, Nov. 2011, 10.1183/09031936.00149810

    2011

  50. [58]

    Animal and cell culture models for cystic fibrosis: which model is right for your application?

    A. McCarron, D. Parsons, and M. Donnelley, “Animal and cell culture models for cystic fibrosis: which model is right for your application?” Am. J. Pathol., vol. 191, no. 2, pp. 228–242, Feb. 2021, 10.1016/j.ajpath. 2020.10.017

    2021 doi

  51. [59]

    µCT to quantify muco-obstructive lung disease and effects of neutrophil elastase knockout in mice,

    L. Zhu et al., “µCT to quantify muco-obstructive lung disease and effects of neutrophil elastase knockout in mice,” Am. J. Physiol. Lung Cell. Mol. Physiol., vol. 322, no. 3, pp. L401–L411, Mar. 2022, 10.1152/ajplung. 00341.2021

    2022

  52. [60]

    Functional lung imaging identifies peripheral ventila- tion changes in mice with muco-obstructive lung disease,

    N. Reyne et al., “Functional lung imaging identifies peripheral ventila- tion changes in mice with muco-obstructive lung disease,” bioRxiv, Jul. 2024, 10.1101/2024.06.27.600946

    2024 doi

  53. [61]

    Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer,

    C. E. Weeden et al., “Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer,” Cancer Cell , vol. 41, no. 5, pp. 837–852, May 2023, 10.1016/j.ccell. 2023.03.019

    2023 doi

  54. [62]

    Methods for dynamic synchrotron X-ray respira- tory imaging in live animals,

    K. S. Morgan et al., “Methods for dynamic synchrotron X-ray respira- tory imaging in live animals,” J. Synchrotron Radiat., vol. 27, no. 1, pp. 164–175, Jan. 2020, 10.1107/S1600577519014863

    2020 doi

  55. [63]

    The ASTRA toolbox: A platform for advanced algorithm development in electron tomography,

    W. Van Aarle et al. , “The ASTRA toolbox: A platform for advanced algorithm development in electron tomography,” Ultramicroscopy, vol. 157, pp. 35–47, Oct. 2015, 10.1016/j.ultramic.2015.05.002

    2015 doi

  56. [64]

    Fast and flexible x-ray tomography using the ASTRA toolbox,

    ——, “Fast and flexible x-ray tomography using the ASTRA toolbox,” Opt. Express, vol. 24, no. 22, pp. 25 129–25 147, Oct. 2016, 10.1364/ OE.24.025129

    2016

  57. [65]

    Grating-based x-ray dark-field computed tomogra- phy of living mice,

    A. Velroyen et al., “Grating-based x-ray dark-field computed tomogra- phy of living mice,” EBioMedicine, vol. 2, no. 10, pp. 1500–1506, Oct. 2015, 10.1016/j.ebiom.2015.08.014

    2015 doi

  58. [66]

    In-vivo x-ray dark-field computed tomography for the detection of radiation-induced lung damage in mice,

    R. Burkhardt et al., “In-vivo x-ray dark-field computed tomography for the detection of radiation-induced lung damage in mice,” Phys. Imaging Radiat. Oncol. , vol. 20, pp. 11–16, Oct. 2021, 10.1016/j.phro.2021.09. 003

    2021 doi

  59. [67]

    Paraxial diffusion-field retrieval,

    D. M. Paganin, D. Pelliccia, and K. S. Morgan, “Paraxial diffusion-field retrieval,” Phys. Rev. A. , vol. 108, no. 1, Jul. 2023, Art. no. 013517, 10.1103/PhysRevA.108.013517

    2023 doi

  60. [68]

    Requirements for dynamical differential phase contrast x-ray imaging with a laboratory source,

    D. Macindoe, M. J. Kitchen, S. C. Irvine, A. Fouras, and K. S. Morgan, “Requirements for dynamical differential phase contrast x-ray imaging with a laboratory source,” Phys. Med. Biol. , vol. 61, no. 24, pp. 8720– 8735, Nov. 2016, 10.1088/1361-6560/61/24/8720

    2016 doi

  61. [69]

    Effect of beam hardening on a visibility-contrast image obtained by X-ray grating interferometry,

    W. Yashiro, P. Vagovi ˇc, and A. Momose, “Effect of beam hardening on a visibility-contrast image obtained by X-ray grating interferometry,” Opt. Express, vol. 23, no. 18, pp. 23 462–23 471, Sep. 2015, 10.1364/ OE.23.023462

    2015

  62. [70]

    A beam hardening and dispersion correction for x-ray dark-field radiography,

    G. Pelzer et al., “A beam hardening and dispersion correction for x-ray dark-field radiography,” Med. Phys., vol. 43, no. 6, pp. 2774–2779, Jun. 2016, 10.1118/1.4948671

    2016 doi

  63. [71]

    Modeling of beam hardening effects in a dual-phase X-ray grating interferometer for quantitative dark-field imaging,

    A. Pandeshwar, M. Kagias, Z. Wang, and M. Stampanoni, “Modeling of beam hardening effects in a dual-phase X-ray grating interferometer for quantitative dark-field imaging,” Opt. Express, vol. 28, no. 13, pp. 19 187–19 204, Jun. 2020, 10.1364/OE.395237

    2020 doi

  64. [72]

    X-ray dark-field signal reduction due to hardening of the visibility spectrum,

    F. De Marco et al., “X-ray dark-field signal reduction due to hardening of the visibility spectrum,” IEEE Trans. Med. Imaging , vol. 43, no. 4, pp. 1422–1433, Nov. 2024, 10.1109/TMI.2023.3337994

    2024

  65. [73]

    Synchrotron- based dynamic computed tomography of tissue motion for regional lung function measurement,

    S. Dubsky, S. B. Hooper, K. K. W. Siu, and A. Fouras, “Synchrotron- based dynamic computed tomography of tissue motion for regional lung function measurement,” J. R. Soc. Interface , vol. 9, no. 74, pp. 2213– 2224, Sep. 2012, 10.1098/rsif.2012.0116

    2012

  66. [74]

    Quantification of heterogeneity in lung disease with image-based pulmonary function testing,

    C. S. Stahr et al., “Quantification of heterogeneity in lung disease with image-based pulmonary function testing,” Sci. Rep. , vol. 6, no. 1, Jul. 2016, Art. no. 29438, 10.1038/srep29438

    2016 doi

  67. [75]

    Real-time in vivo imaging of regional lung function in a mouse model of cystic fibrosis on a laboratory X-ray source,

    R. P. Murrie et al. , “Real-time in vivo imaging of regional lung function in a mouse model of cystic fibrosis on a laboratory X-ray source,” Sci. Rep. , vol. 10, no. 1, Jan. 2020, Art. no. 447, 10.1038/ s41598-019-57376-w

    2020

  68. [76]

    Quantification of muco-obstructive lung disease variability in mice via laboratory x-ray velocimetry,

    F. Werdiger et al. , “Quantification of muco-obstructive lung disease variability in mice via laboratory x-ray velocimetry,” Sci. Rep., vol. 10, no. 1, Jul. 2020, Art. no. 10859, 10.1038/s41598-020-67633-y

    2020 doi

  69. [77]

    Using X-ray tomoscopy to explore the dynam- ics of foaming metal,

    F. Garc ´ıa-Moreno et al., “Using X-ray tomoscopy to explore the dynam- ics of foaming metal,” Nat. Commun. , vol. 10, no. 1, Aug. 2019, Art. no. 3762, 10.1038/s41467-019-11521-1

    2019 doi

  70. [78]

    Study of precipitation reactions by X-ray microscopy: CaCO 3 precipitation and the effect of poly- carboxylates,

    J. Rieger, J. Thieme, and C. Schmidt, “Study of precipitation reactions by X-ray microscopy: CaCO 3 precipitation and the effect of poly- carboxylates,” Langmuir, vol. 16, no. 22, pp. 8300–8305, Oct. 2000, 10.1021/la0004193

    doi

  71. [79]

    Structural and chemical characterization of precipitates in Al-2024/TiC composites,

    A. Albiter, A. Contreras, E. Bedolla, and R. Perez, “Structural and chemical characterization of precipitates in Al-2024/TiC composites,” Compos. - A: Appl. Sci. Manuf. , vol. 34, no. 1, pp. 17–24, Jan. 2003, 10.1016/S1359-835X(02)00259-2

    2024 doi

  72. [80]

    Directional x-ray dark-field imaging,

    T. H. Jensen et al., “Directional x-ray dark-field imaging,” Phys. Med. Biol., vol. 55, no. 12, pp. 3317–3323, May 2010, 10.1088/0031-9155/ 55/12/004

    2010 doi

  73. [81]

    Directional x-ray dark-field imaging of strongly ordered sys- tems,

    ——, “Directional x-ray dark-field imaging of strongly ordered sys- tems,” Phys. Rev. B. , vol. 82, Dec. 2010, Art. no. 214103, 10.1103/ PhysRevB.82.214103

    2010

  74. [82]

    Ultra-fast in vivo directional dark-field x-ray imaging for visualising magnetic control of particles for airway gene delivery,

    R. Smith et al., “Ultra-fast in vivo directional dark-field x-ray imaging for visualising magnetic control of particles for airway gene delivery,” Phys. Med. Biol. , vol. 69, no. 10, May 2024, Art. no. 105025, 10.1088/ 1361-6560/ad40f5

    2024

  75. [83]

    Correcting directional dark field x-ray imaging artefacts using position dependent image deblurring and attenuation removal,

    M. K. Croughan et al., “Correcting directional dark field x-ray imaging artefacts using position dependent image deblurring and attenuation removal,” Sci. Rep. , vol. 14, no. 1, Aug. 2024, Art. no. 17807, 10.1038/s41598-024-68659-2

    2024 doi

  76. [84]

    Tomographic in vivo microscopy for the study of lung physiology at the alveolar level,

    G. Lovric et al., “Tomographic in vivo microscopy for the study of lung physiology at the alveolar level,” Sci. Rep., vol. 7, no. 1, Oct. 2017, Art. no. 12545, 10.1038/s41598-017-12886-3

    2017 doi

  77. [2012]

    Available: {A}rt.no.063813,\url{10.1103/PhysRevA

    [Online]. Available: {A}rt.no.063813,\url{10.1103/PhysRevA. 86.063813}

    doi

Pith tools

Reviewed August 12, 2026 · model on record in the stance chip above.